Amyris bets on sweet proteins with Oobli acquisition
The deal will combine Oobli’s protein production platform and portfolio with Amyris’ strain engineering and biomanufacturing capabilities.
The deal will combine Oobli’s protein production platform and portfolio with Amyris’ strain engineering and biomanufacturing capabilities.
“We don’t assume every attempt can be prevented, so our focus is on building the readiness to identify threats early and act decisively,” says Brian Cincera.
Iran has denied it was behind the recent cyberattacks on more than 700 food retail …